# Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients

> **NCT01291537** · PHASE2 · COMPLETED · sponsor: **Poitiers University Hospital** · enrollment: 56 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Duodopa
- **DRUG:** best médical treatment

## Key facts

- **NCT ID:** NCT01291537
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2016-03
- **Final completion:** —
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2016-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291537, "Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01291537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*